Sign In
Buy ANTH
Anthera Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 11.02M and sold 541.51K ANTH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
0 |
| ● Buy | 11.02M shares |
| ● Sell | 541.51K shares |
|
92% Buy Activity
Negligible or No Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Apr 27, 2016 Buy |
Furse Brent Director |
33 670 Value: $127.9K |
||
|
Apr 27, 2016 Buy |
Furse Brent Director |
33 670 Value: $127.9K |
||
|
Apr 27, 2016 Buy |
Thompson David E. Director |
41 379 Value: $157.2K |
||
|
Apr 27, 2016 Buy |
Sager Philip Director |
41 379 Value: $157.2K |
||
|
Apr 27, 2016 Buy |
Engle Steven B Director |
41 379 Value: $157.2K |
||
|
Apr 27, 2016 Buy |
Mueller Brian Director |
41 379 Value: $157.2K |
||
|
Apr 27, 2016 Buy |
Henney Christopher S Director |
62 069 Value: $235.9K |
||
|
Apr 01, 2016 Buy |
Pennington James Interim Chief Medical Officer |
0 Value: $0 |
||
|
Apr 01, 2016 Buy |
Pennington James Interim Chief Medical Officer |
25 000 Value: $122.0K |
||
|
Apr 01, 2016 Buy |
Pennington James Interim Chief Medical Officer |
20 000 Value: $31.6K |
||
|
Apr 01, 2016 Buy |
Pennington James Interim Chief Medical Officer |
70 000 Value: $332.5K |
||
|
Apr 01, 2016 Buy |
Pennington James Interim Chief Medical Officer |
20 000 Value: $68.8K |
||
|
Apr 01, 2016 Buy |
Pennington James Interim Chief Medical Officer |
45 000 Value: $168.8K |
||
|
Apr 01, 2016 Buy |
Pennington James Interim Chief Medical Officer |
45 000 Value: $168.8K |
||
|
Apr 01, 2016 Buy |
Pennington James Interim Chief Medical Officer |
20 000 Value: $68.8K |
||
|
Apr 01, 2016 Buy |
Pennington James Interim Chief Medical Officer |
70 000 Value: $332.5K |
||
|
Apr 01, 2016 Buy |
Pennington James Interim Chief Medical Officer |
20 000 Value: $31.6K |
||
|
Apr 01, 2016 Buy |
Pennington James Interim Chief Medical Officer |
25 000 Value: $122.0K |
||
|
Apr 01, 2016 Buy |
Pennington James Interim Chief Medical Officer |
0 Value: $0 |
||
|
Feb 12, 2016 Buy |
Hislop Colin Chief Medical Officer |
10 848 Value: $31.0K |
||
|
Feb 12, 2016 Buy |
Dickinson Klara Chief Regulatory Officer |
8 395 Value: $24.0K |
||
|
Feb 18, 2009 Buy |
Pennington James Interim Chief Medical Officer |
3 651 Value: $44.1K |
||
|
Feb 18, 2009 Buy |
Pennington James Interim Chief Medical Officer |
3 651 Value: $44.1K |
||
|
Jan 23, 2007 Buy |
Truex Paul F Chief Executive Officer |
5 008 Value: $10.4K |
||
|
Jan 23, 2007 Buy |
Truex Paul F Chief Executive Officer |
5 008 Value: $10.4K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
